JP2020502054A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020502054A5 JP2020502054A5 JP2019524383A JP2019524383A JP2020502054A5 JP 2020502054 A5 JP2020502054 A5 JP 2020502054A5 JP 2019524383 A JP2019524383 A JP 2019524383A JP 2019524383 A JP2019524383 A JP 2019524383A JP 2020502054 A5 JP2020502054 A5 JP 2020502054A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- use according
- item
- administration
- food
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022015514A JP7495951B2 (ja) | 2016-11-30 | 2022-02-03 | 抗線維化療法を投与する方法 |
| JP2023118969A JP2023139157A (ja) | 2016-11-30 | 2023-07-21 | 抗線維化療法を投与する方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662428163P | 2016-11-30 | 2016-11-30 | |
| US62/428,163 | 2016-11-30 | ||
| US201662432425P | 2016-12-09 | 2016-12-09 | |
| US62/432,425 | 2016-12-09 | ||
| PCT/US2017/063549 WO2018102323A1 (en) | 2016-11-30 | 2017-11-29 | Methods of administering anti-fibrotic therapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022015514A Division JP7495951B2 (ja) | 2016-11-30 | 2022-02-03 | 抗線維化療法を投与する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020502054A JP2020502054A (ja) | 2020-01-23 |
| JP2020502054A5 true JP2020502054A5 (https=) | 2021-01-14 |
Family
ID=60655162
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019524383A Pending JP2020502054A (ja) | 2016-11-30 | 2017-11-29 | 抗線維化療法を投与する方法 |
| JP2022015514A Active JP7495951B2 (ja) | 2016-11-30 | 2022-02-03 | 抗線維化療法を投与する方法 |
| JP2023118969A Withdrawn JP2023139157A (ja) | 2016-11-30 | 2023-07-21 | 抗線維化療法を投与する方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022015514A Active JP7495951B2 (ja) | 2016-11-30 | 2022-02-03 | 抗線維化療法を投与する方法 |
| JP2023118969A Withdrawn JP2023139157A (ja) | 2016-11-30 | 2023-07-21 | 抗線維化療法を投与する方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US11207304B2 (https=) |
| EP (2) | EP4470624A3 (https=) |
| JP (3) | JP2020502054A (https=) |
| KR (3) | KR20230129628A (https=) |
| CN (1) | CN110087651A (https=) |
| AU (3) | AU2017366881A1 (https=) |
| CA (2) | CA3247781A1 (https=) |
| IL (3) | IL299447A (https=) |
| MX (3) | MX2019006143A (https=) |
| TW (3) | TW202539656A (https=) |
| WO (1) | WO2018102323A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11207304B2 (en) | 2016-11-30 | 2021-12-28 | Genentech, Inc. | Methods of administering anti-fibrotic therapy |
| CN114129517A (zh) * | 2020-09-03 | 2022-03-04 | 苏州爱科百发生物医药技术有限公司 | 一种ak3287制剂及其制备方法和应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR092742A1 (es) | 2012-10-02 | 2015-04-29 | Intermune Inc | Piridinonas antifibroticas |
| MX382781B (es) | 2014-04-02 | 2025-03-13 | Intermune Inc | Piridinonas anti-fibroticas. |
| US11207304B2 (en) | 2016-11-30 | 2021-12-28 | Genentech, Inc. | Methods of administering anti-fibrotic therapy |
-
2017
- 2017-11-29 US US16/465,015 patent/US11207304B2/en active Active
- 2017-11-29 TW TW114123565A patent/TW202539656A/zh unknown
- 2017-11-29 KR KR1020237029765A patent/KR20230129628A/ko not_active Ceased
- 2017-11-29 MX MX2019006143A patent/MX2019006143A/es unknown
- 2017-11-29 EP EP24206151.3A patent/EP4470624A3/en not_active Withdrawn
- 2017-11-29 TW TW106141628A patent/TWI826361B/zh active
- 2017-11-29 AU AU2017366881A patent/AU2017366881A1/en not_active Abandoned
- 2017-11-29 CN CN201780074290.6A patent/CN110087651A/zh active Pending
- 2017-11-29 IL IL299447A patent/IL299447A/en unknown
- 2017-11-29 EP EP17812223.0A patent/EP3548025A1/en not_active Withdrawn
- 2017-11-29 KR KR1020227034429A patent/KR102575344B1/ko active Active
- 2017-11-29 KR KR1020197013644A patent/KR20190089862A/ko not_active Ceased
- 2017-11-29 JP JP2019524383A patent/JP2020502054A/ja active Pending
- 2017-11-29 CA CA3247781A patent/CA3247781A1/en active Pending
- 2017-11-29 WO PCT/US2017/063549 patent/WO2018102323A1/en not_active Ceased
- 2017-11-29 TW TW112145288A patent/TWI891129B/zh active
- 2017-11-29 CA CA3045455A patent/CA3045455A1/en active Pending
-
2019
- 2019-05-06 IL IL266480A patent/IL266480A/en unknown
- 2019-05-27 MX MX2023003924A patent/MX2023003924A/es unknown
- 2019-05-27 MX MX2020011766A patent/MX2020011766A/es unknown
-
2021
- 2021-11-17 US US17/528,537 patent/US11925624B2/en active Active
-
2022
- 2022-01-02 IL IL289544A patent/IL289544B2/en unknown
- 2022-02-03 JP JP2022015514A patent/JP7495951B2/ja active Active
-
2023
- 2023-07-21 JP JP2023118969A patent/JP2023139157A/ja not_active Withdrawn
- 2023-11-10 AU AU2023263548A patent/AU2023263548B2/en active Active
-
2024
- 2024-02-13 US US18/440,652 patent/US12310951B2/en active Active
-
2025
- 2025-09-29 AU AU2025238129A patent/AU2025238129A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6170040B2 (ja) | ピルフェニドン及び選択された患者における抗線維化療法 | |
| Ben Salem et al. | Drug-induced hyperkalemia | |
| Berl et al. | Oral tolvaptan is safe and effective in chronic hyponatremia | |
| AU2017245601C1 (en) | Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease | |
| KR20230125826A (ko) | 멜록시캄을 포함하는 약학 조성물 | |
| CA3053991A1 (en) | Combinations of a 4-pyrimidinesulfamide derivative with active ingredients for the treatment of endothelin related diseases | |
| JP2019108356A (ja) | キサンチンオキシダーゼ阻害剤を用いた治療方法及びそれを含む組成物 | |
| KR20220164557A (ko) | 멜록시캄을 포함하는 제약 조성물 | |
| US20160206617A1 (en) | Compositions and therapeutic methods for accelerated plaque regression | |
| JP2014532726A5 (https=) | ||
| RU2019111421A (ru) | Способы лечения острого повреждения почек | |
| JP2020500864A5 (https=) | ||
| US20040235802A1 (en) | Combinations comprising cox-2-inhibitors and aspirin | |
| JPWO2013089164A1 (ja) | 高度腎機能障害を有する血栓塞栓症患者の血栓塞栓症の予防治療剤 | |
| JP2020502054A5 (https=) | ||
| JP6509729B2 (ja) | 慢性腎臓病の進行抑制又は改善剤 | |
| JP2023139157A (ja) | 抗線維化療法を投与する方法 | |
| Maekawa et al. | Successful treatment of refractory gout using combined therapy consisting of febuxostat and allopurinol in a patient with chronic renal failure | |
| JP2005513167A5 (https=) | ||
| JP6885649B2 (ja) | 統合失調症の治療のためのイロペリドン | |
| Pape et al. | Effect of esomeprazole on the oral absorption of dasatinib in a patient with Philadelphia‐positive acute lymphoblastic leukemia | |
| JP6684264B2 (ja) | 心不全の予防又は治療のための医薬 | |
| AU2020313310A1 (en) | Dose dumping resistant pharmaceutical compositions comrising verinurad | |
| US20260041677A1 (en) | Compositions and methods for treating adenoid cystic carcinoma | |
| CN111526875A (zh) | 用于治疗骨关节炎疼痛的mPGES-1抑制剂 |